Quetiapine Fumarate Tablet
Product Images NDC 60760-763

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 60760-763). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (6579b4dc Fb3e 418e 821e C0d22e9e8616 1584 1)

Quetiapine fumarate 200 mg oral tablets packaging label from St. Mary's Medical Park Pharmacy. The label shows a plain white tablet container or blister featuring the product name, strength, dosage form, and labeler information. The packaging is simple with legible text identifying the prescription drug.*

FDA Label Image

Molecular Structure (9fb56acd 2611 4c7d B63f 1de0c57383ea 01)

Chemical structure of quetiapine fumarate, showing the molecular components of quetiapine with its characteristic dibenzothiazepine ring and piperazine moiety, combined with the fumarate ion structure.*

FDA Label Image

Figure 1 (9fb56acd 2611 4c7d B63f 1de0c57383ea 02)

A Kaplan-Meier survival curve chart comparing the proportion of patients with relapse (%) over time (weeks) between two treatment groups: QTP+LI/VAL (dashed line) and PLA+LI/VAL (solid line). The chart shows relapse proportions increasing over time, with distinct relapse patterns between the two groups within 100 weeks.*

FDA Label Image

Figure 2 (9fb56acd 2611 4c7d B63f 1de0c57383ea 03)

A Kaplan-Meier plot showing the proportion of patients with relapse (%) over time (weeks). Two groups are compared: QTP+LI/VAL represented by a dashed line, and PLA+LI/VAL represented by a solid line. The graph depicts relapse rates increasing over 100 weeks, with the PLA+LI/VAL group showing higher relapse proportions than the QTP+LI/VAL group.*

FDA Label Image

Image (9fb56acd 2611 4c7d B63f 1de0c57383ea 1628 1)

Quetiapine fumarate 200 mg oral tablets in a blister pack. The pack contains ten round tablets arranged in two columns of five each. The labeler is St. Mary's Medical Park Pharmacy. The packaging shows the product name and strength clearly on the foil backing.*

FDA Label Image

Q (Quetiapine 60760 763 30)

Quetiapine Tablets USP 200 mg oral tablets label showing a quantity of 30 tablets. The label indicates manufacture by Lupin Limited, Goa, India, and packaging by St. Mary's Medical Park Pharmacy in Oro Valley, Arizona. The label includes NDC 60760-763-30 and placeholder data for lot number and expiration date, along with instructions to use as directed and store at controlled room temperature (15°-30°C).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.